Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: Implications for obesity, depression and alcoholism

Neuropsychopharmacology

Volumn 36, Issue 11, 2011, Pages 2211-2221

  Davidson, Scott ^a   Lear, Marissa ^a   Shanley, Lynne ^a   Hing, Benjamin ^a   Baizan Edge, Amanda ^a   Herwig, Annika ^b   Quinn, John P ^c   Breen, Gerome ^d   McGuffin, Peter ^d   Starkey, Andrew ^e   Barrett, Perry ^b   MacKenzie, Alasdair ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

alcoholism; amygdala; Galanin; major depressive disorder; obesity; polymorphisms

Indexed keywords

GALANIN LIKE PEPTIDE;

ALCOHOLISM; ALLELE; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE ACTIVITY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; MAJOR DEPRESSION; MOUSE; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; OBESITY; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALCOHOLISM; AMYGDALA; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELLS, CULTURED; DEPRESSION; ENHANCER ELEMENTS, GENETIC; GALANIN; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; HYPOTHALAMUS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS;

EID: 80052720242     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.93     Document Type: Article

References (71)

1. Adams AC, Clapham JC, Wynick D, Speakman JR (2008). Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference. J Neuroendocrinol 20: 199-206. (Pubitemid 351147007)
2. Azumaya Y, Tsutsui K (1996). Localization of galanin and its binding sites in the quail brain. Brain Res 727: 187-195. (Pubitemid 26246828)
3. Bacon A, Kerr NC, Holmes FE, Gaston K, Wynick D (2007). Characterization of an enhancer region of the galanin gene that directs expression to the dorsal root ganglion and confers responsiveness to axotomy. J Neurosci 27: 6573-6580. (Pubitemid 46920372)
4. Barker-Gibb ML, Clarke IJ (1996). Increased galanin and neuropeptide-Y immunoreactivity within the hypothalamus of ovariectomised ewes following a prolonged period of reduced body weight is associated with changes in plasma growth hormone but not gonadotropin levels. Neuroendocrinology 64: 194-207. (Pubitemid 26280812)
5. Barr AM, Kinney JW, Hill MN, Lu X, Biros S, Rebek Jr J et al (2006). A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neurosci Lett 405: 111-115.
6. Belfer I, Hipp H, McKnight C, Evans C, Buzas B, Bollettino A et al (2006). Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 11: 301-311.
7. Ceccatelli S, Eriksson M, Hokfelt T (1989). Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin-and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocri-nology 49: 309-323. (Pubitemid 19095272)
8. Ceccatelli S, Giardino L, Calza L (1992). Response of hypothalamic peptide mRNAs to thyroidectomy. Neuroendocrinology 56: 694-703. (Pubitemid 23033832)
9. Cortes R, Villar MJ, Verhofstad A, Hokfelt T (1990). Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc Natl Acad Sci USA 87: 7742-7746. (Pubitemid 20341793)
10. Crawley JN, Mufson EJ, Hohmann JG, Teklemichael D, Steiner RA, Holmberg K et al (2002). Galanin overexpressing transgenic mice. Neuropeptides 36: 145-156.
11. Davidson S, Miller KA, Dowell A, Gildea A, Mackenzie A (2006a). Cellular co-expression of a LacZ marker gene driven by the amygdala-specific ECR1 enhancer with the substance P neuro-peptide. Mol Psychiatry 11: 323.
12. Davidson S, Miller KA, Dowell A, Gildea A, Mackenzie A (2006b). A remote and highly conserved enhancer supports amygdala specific expression of the gene encoding the anxiogenic neuropeptide substance-P. Mol Psychiatry 11: 410-421.
13. Evans HF, Huntley GW, Morrison JH, Shine J (1993). Localisation of mRNA encoding the protein precursor of galanin in the monkey hypothalamus and basal forebrain. J Comp Neurol 328: 203-212. (Pubitemid 23057960)
14. Gillies SG, Haddley K, Vasiliou SA, Jacobson GM, von Mentzer B, Bubb VJ et al (2010). Distinct gene expression profiles directed by the isoforms of the transcription factor neuron-restrictive silencer factor in human SK-N-AS neuroblastoma cells. J Mol Neurosci 44: 77-90.
15. Hindorff LA, Burke W, Laberge AM, Rice KM, Lumley T, Leppig K et al (2009). Motivating factors for physician ordering of factor V Leiden genetic tests. Arch Intern Med 169: 68-74.
16. Hobson SA, Holmes FE, Kerr NC, Pope RJ, Wynick D (2006). Mice deficient for galanin receptor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour. J Neurochem 99: 1000-1010. (Pubitemid 44583456)
17. Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, Ma L et al (2003). Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology 28: 1031-1044.
18. Holmes A, Picciotto MR (2006). Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction? CNS Neurol Disord Drug Targets 5: 225-232. (Pubitemid 43796622)
19. Kaplan LM, Spindel ER, Isselbacher KJ, Chin WW (1988). Tissue-specific expression of the rat galanin gene. Proc Natl Acad Sci USA 85: 1065-1069.
20. Karatayev O, Barson JR, Chang GQ, Leibowitz SF (2009a). Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: possible mechanism underlying their behavioral effects. Peptides 30: 2423-2431.
21. Karatayev O, Baylan J, Leibowitz SF (2009b). Increased intake of ethanol and dietary fat in galanin overexpressing mice. Alcohol 43: 571-580.
22. Karatayev O, Baylan J, Weed V, Chang S, Wynick D, Leibowitz SF (2009c). Galanin knockout mice show disturbances in ethanol consumption and expression of hypothalamic peptides that stimulate ethanol intake. Alcohol Clin Exp Res 34: 72-80.
23. Karlsson RM, Holmes A (2006). Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease. Amino Acids 31: 231-239. (Pubitemid 44537049)
24. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al (2002). The human genome browser at UCSC. Genome Res 12: 996-1006. (Pubitemid 34662293)
25. Kuteeva E, Hokfelt T, Wardi T, Ogren SO (2008a). Galanin, galanin receptor subtypes and depression-like behaviour. Cell Mol Life Sci 65: 1854-1863.
26. Kuteeva E, Wardi T, Hokfelt T, Ogren SO (2007). Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat. Eur Neuropsychopharmacol 17: 64-69. (Pubitemid 44751405)
27. Kuteeva E, Wardi T, Lundstrom L, Sollenberg U, Langel U, Hokfelt T et al (2008b). Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychopharmacology 33: 2573-2585.
28. Leibowitz SF (2005). Regulation and effects of hypothalamic galanin: relation to dietary fat, alcohol ingestion, circulating lipids and energy homeostasis. Neuropeptides 39: 327-332. (Pubitemid 40804606)
29. Leibowitz SF (2007). Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides. Physiol Behav 91: 513-521. (Pubitemid 47247786)
30. Leibowitz SF, Avena NM, Chang GQ, Karatayev O, Chau DT, Hoebel BG (2003). Ethanol intake increases galanin mRNA in the hypothalamus and withdrawal decreases it. Physiol Behav 79: 103-111. (Pubitemid 36734834)
31. Leibowitz SF, Kim T (1992). Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Brain Res 599: 148-152. (Pubitemid 23024928)
32. Lu X, Sharkey L, Bartfai T (2007). The brain galanin receptors: targets for novel antidepressant drugs. CNS Neurol Disord Drug Targets 6: 183-192. (Pubitemid 46916250)
33. Mackenzie A, Miller KA, Collinson JM (2004a). Is there a functional link between gene interdigitation and multi-species conservation of synteny blocks? Bioessays 26: 1217-1224. (Pubitemid 39536617)
34. MacKenzie A, Purdie L, Davidson D, Collinson M, Hill RE (1997). Two enhancer domains control early aspects of the complex expression pattern of Msx1. Mech Dev 62: 29-40. (Pubitemid 27165377)
35. MacKenzie A, Quinn JP (2004b). Post-genomic approaches to exploring neuropeptide gene mis-expression in disease. Neuro-peptides 38: 1-15. (Pubitemid 38372959)
36. Madaan V, Wilson DR (2009). Neuropeptides: relevance in treatment of depression and anxiety disorders. Drug News Perspect 22: 319-324.
37. Mercer JG, Lawrence CB, Atkinson T (1996). Regulation of galanin gene expression in the hypothalamic paraventricular nucleus of the obese Zucker rat by manipulation of dietary macronutrients. Brain Res Mol Brain Res 43: 202-208. (Pubitemid 27042407)
38. Miller KA, Barrow J, Collinson JM, Davidson S, Lear M, Hill RE et al (2007). A highly conserved Wnt-dependent TCF4 binding site within the proximal enhancer of the anti-myogenic Msx1 gene supports expression within Pax3-expressing limb bud muscle precursor cells. Dev Biol 311: 665-678. (Pubitemid 350046522)
39. Miller KA, Davidson S, Liaros A, Barrow J, Lear M, Heine D et al (2008). Prediction and characterisation of a highly conserved, remote and cAMP responsive enhancer that regulates Msx1 gene expression in cardiac neural crest and outflow tract. Dev Biol 317: 686-694.
40. Miller MA, Kolb PE, Raskind MA (1993a). Extra-hypothalamic vasopressin neurons coexpress galanin messenger RNA as shown by double in situ hybridization histochemistry. J Comp Neurol 329: 378-384. (Pubitemid 23078232)
41. Miller MA, Kolb PE, Raskind MA (1993b). Testosterone regulates galanin gene expression in the bed nucleus of the stria terminalis. Brain Res 611: 338-341. (Pubitemid 23159705)
42. Mongin E, Dewar K, Blanchette M (2009). Long-range regulation is a major driving force in maintaining genome integrity. BMC Evol Biol 9: 203.
43. Nagy AG, Vinterstein M, K, Behringer R (2003). Manipulating the Mouse Embryo 3rd edn Cold Spring Harbor Laboratory Press: Cold Spring Harbor.
44. Naito S, Shimizu S, Matsuu M, Nakashima M, Nakayama T, Yamashita S et al (2002). Ets-1 upregulates matrix metalloprotei-nase-1 expression through extracellular matrix adhesion in vascular endothelial cells. Biochem Biophys Res Commun 291: 130-138. (Pubitemid 34681148)
45. Navratilova P, Becker TS (2009a). Genomic regulatory blocks in vertebrates and implications in human disease. Brief Funct Genomic Proteomic 8: 333-342.
46. Navratilova P, Fredman D, Hawkins TA, Turner K, Lenhard B, Becker TS (2009b). Systematic human/Zebrafish comparative identification of cis-regulatory activity around vertebrate developmental transcription factor genes. Dev Biol 327: 526-540.
47. Ovcharenko I, Nobrega MA, Loots GG, Stubbs L (2004). ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 32(Web Server issue): W280-W286. (Pubitemid 38997344)
48. Paschos KA, Veletza S, Chatzaki E (2009). Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression. CNS Drugs 23: 755-772.
49. Paxinos KBJFaG (1997). The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, CA.
50. Picciotto MR, Brabant C, Einstein EB, Kamens HM, Neugebauer NM (2010). Effects of galanin on monoaminergic systems and HPA axis: potential mechanisms underlying the effects of galanin on addiction-and stress-related behaviors. Brain Res 1314: 206-218.
51. Plaisier CL, Kyttala M, Weissglas-Volkov D, Sinsheimer JS, Huertas-Vazquez A, Riba L et al (2009). Galanin preproprotein is associated with elevated plasma triglycerides. Arterioscler Thromb Vasc Biol 29: 147-152.
52. Planas B, Kolb PE, Raskind MA, Miller MA (1994a). Activation of galanin pathways across puberty in the male rat: galanin gene expression in the bed nucleus of the stria terminalis and medial amygdala. Neuroscience 63: 851-858. (Pubitemid 24360237)
53. Planas B, Kolb PE, Raskind MA, Miller MA (1994b). Galanin in the bed nucleus of the stria terminalis and medial amygdala of the rat: lack of sexual dimorphism despite regulation of gene expression across puberty. Endocrinology 134: 1999-2004. (Pubitemid 24142934)
54. Poritsanos NJ, Mizuno TM, Lautatzis ME, Vrontakis M (2009). Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int J Obes (Lond) 33: 1381-1389.
55. Rada P, Mark GP, Hoebel BG (1998). Galanin in the hypothalamus raises dopamine and lowers acetylcholine release in the nucleus accumbens: a possible mechanism for hypothalamic initiation of feeding behavior. Brain Res 798: 1-6. (Pubitemid 28342014)
56. Rokaeus A, Waschek JA (1998). Tissue-specific enhancement and restriction of galanin gene expression in transgenic mice by 50 flanking sequences. Brain Res Mol Brain Res 60: 150-159. (Pubitemid 28466580)
57. Rotzinger S, Lovejoy DA, Tan LA (2009). Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31: 736-756.
58. Ruano G, Windemuth A, Kocherla M, Holford T, Fernandez ML, Forsythe CE et al (2006). Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction. Nutr Metab (Lond) 3: 20.
59. Schauble N, Reichwald K, Grassl W, Bechstein H, Muller HC, Scherag A et al (2005). Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity. J Nutr 135: 1387-1392. (Pubitemid 40799600)
60. Scott IG, Akerman KE, Heikkila JE, Kaila K, Andersson LC (1986). Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cells. J Cell Physiol 128: 285-292. (Pubitemid 16047940)
61. Sergeyev V, Fetissov S, Mathe AA, Jimenez PA, Bartfai T, Mortas P et al (2005). Neuropeptide expression in rats exposed to chronic mild stresses. Psychopharmacology (Berl) 178: 115-124. (Pubitemid 40379205)
62. Shanley L, Davidson S, Lear M, Thotakura AK, McEwan IJ, Ross RA et al (2010). Long-range regulatory synergy is required to allow control of the TAC1 locus by MEK/ERK signalling in sensory neurones. Neurosignals 18: 173-85.
63. Shanley L, Lear M, Davidson S, Ross R, Mackenzie A (2011). Evidence for regulatory diversity and auto-regulation at the TAC1 locus in sensory neurones. J Neuroinflammation 8: 10.
64. Singleton AB, Hardy J, Traynor BJ, Houlden H (2010). Towards a complete resolution of the genetic architecture of disease. Trends Genet 26: 438-442.
65. Unschuld PG, Ising M, Erhardt A, Lucae S, Kohli M, Kloiber S et al (2008). Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord 105: 177-184. (Pubitemid 350236362)
66. Unschuld PG, Ising M, Roeske D, Erhardt A, Specht M, Kloiber S et al (2010). Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepres-sant treatment response. Neuropsychopharmacology 35: 1583-1592.
67. Vetter M, Blumenthal SG, Lindemann RK, Manns J, Wesselborg S, Thomssen C et al (2005). Ets1 is an effector of protein kinase Calpha in cancer cells. Oncogene 24: 650-661. (Pubitemid 40188569)
68. Wray GA (2007). The evolutionary significance of cis-regulatory mutations. Nat Rev Genet 8: 206-216.
69. Wray NR, Pergadia ML, Blackwood DH, Penninx BW, Gordon SD, Nyholt DR et al (2010). Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry.
70. Wynick D, Bacon A (2002). Targeted disruption of galanin: new insights from knock-out studies. Neuropeptides 36: 132-144.
71. Yee SP, Rigby PW (1993). The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev 7: 1277-1289. (Pubitemid 23207417)